What is the global market size of the Cardioverter Defibrillator Device Market?

Global Cardioverter Defibrillator Device Market size was valued at USD 11.19 billion in 2021 and is poised to grow to USD 20.8 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

Global Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type(implantable cardioverter defibrillators, external cardioverter defibrillators), By End use(hospitals, pre-hospital) - Industry Forecast 2024-2031

Report ID: SQMIG35A2207 | Region: Global | Published Date: February, 2024
Pages: 224 | Tables: 64 | Figures: 75

Global Cardioverter Defibrillator Device Market Regional Insights

North America is expected to hold the largest market share during the forecast period due to initiatives taken by key players, favorable regulations, and advanced technological facilities in the U.S and Canada.

In 2020, Bostan Scientific distributed about 33,000 CRT-Ds line up that include Resonate, Autogen, Dynagen, Incepta, and Cognis devices worldwide. Out of these, 16,500 were registered in the U.S alone indicating high adoption rate.

Asia Pacific region is projected to expand at the fastest CAGR during the forecast period. The market growth is attributed to the developing healthcare infrastructure, high patient population, and prevalence of cardiac diseases. regional growth is fast due to the Japanese market having high penetration of defibrillators and supportive policies

Global Cardioverter Defibrillator Device Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cardioverter Defibrillator Device Market size was valued at USD 11.19 billion in 2019 and is poised to grow to USD 20.8 billion by 2031, growing at a CAGR of 7.2% in the forecast period (2024-2031).

Global cardioverter defibrillator devices market is highly competitive. Implantable cardioverter defibrillator key market players are Medtronic PLC, Abbott Laboratories, and Boston Scientific Corporation. Koninklijke Philips N.V., Cardiac Science Corporation, and Zoll Medical Corporation are leading the external defibrillator market. Key players undergo mergers and acquisitions to produce innovative products. They also focus on strengthening their position in the global market. 'Medtronic plc', 'Abbott Laboratories', 'Boston Scientific Corporation', 'Biotronik SE & Co. KG', 'Koninklijke Philips N.V.', 'LivaNova PLC', 'Microport Scientific Corporation', 'Nihon Kohden Corporation', 'Progetti Srl', 'Schiller AG', 'Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)', 'Stryker Corporation', 'Defibtech, LLC', 'Cardiac Science Corporation', 'Physio-Control International (a subsidiary of Stryker Corporation)', 'CU Medical Systems, Inc.', 'Fukuda Denshi Co., Ltd.', 'Mindray Medical International Limited', 'Welch Allyn, Inc. (a subsidiary of Hill-Rom Holdings, Inc.)', 'Cardionet (a subsidiary of BioTelemetry, Inc.)'

Defibrillators have improved in terms of cost, size reduction, and ease of operation. The advancement in technology is as follows- automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices are effective in controlling cardiac attack conditions. Due to technological advancements in defibrillators, the operating defibrillator has become easy for an observer post-induction of proper training. In April 2019, Biotronik, a Medical Device Company launched the Acticor device family of new implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillator (CRT-Ds).

Smart pacemaker is a device that can detect even the smallest irregularity in the functioning of the heart. Smart pacemakers rectify the abnormalities in the heart and reestablish normal body function. It also alerts the patients as well as physicians about the patient's cardiac health. This feature of the smart maker helps to decrease the mortality rate.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type(implantable cardioverter defibrillators, external cardioverter defibrillators), By End use(hospitals, pre-hospital) - Industry Forecast 2024-2031

Global Cardioverter Defibrillator Device Market Regional Insights

Global Cardioverter Defibrillator Device Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cardioverter Defibrillator Device Market?

Who are the key vendors in the Global Cardioverter Defibrillator Device Market?

What is the key driver of Global Cardioverter Defibrillator Device Market?

What is the key market trend for Global Cardioverter Defibrillator Device Market?

Which region accounted for the largest share in Global Cardioverter Defibrillator Device Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300